Trial · NCT03017846
Adverse events22
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 22
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Tooth Fracture | Gastrointestinal disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Pain | General disorders | Cantharidin Treatment | 2 | 30 | 2 |
| other | Pyrexia | General disorders | Cantharidin Treatment | 3 | 30 | 3 |
| other | Hypersensitivity | Immune system disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Pharyngitis Streptococcal | Infections and infestations | Cantharidin Treatment | 1 | 30 | 1 |
| other | Headache | Nervous system disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Cantharidin Treatment | 4 | 30 | 4 |
| other | Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Application Site Discoloration | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 12 | 30 | 12 |
| other | Application Site Vesicles | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 21 | 30 | 21 |
| other | Dermatitis Atopic | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Eczema | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 2 | 30 | 2 |
| other | Erythema | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 6 | 30 | 6 |
| other | Excoriation | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 2 | 30 | 2 |
| other | Impetigo | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 1 | 30 | 1 |
| other | Skin pain | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 3 | 30 | 3 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 8 | 30 | 8 |
| other | Rash | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 3 | 30 | 3 |
| other | Rash Erythematous | Skin and subcutaneous tissue disorders | Cantharidin Treatment | 1 | 30 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03017846/events